Jeffery Duncan, DO
Orthopaedic Surgery · Altus, OKNPI 1255480885
Payments from drug & device makers
Across 48 payments — averaging $48.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Zimmer Biomet$1K
- Arthrex$546
- Pylant Medical$272
- Stryker$125
- Pacira Therapeutics, Inc.$94
- Pacira Pharmaceuticals Incorporated$66
- plus $207 from 8 others
What the payments were for
- Travel & lodging$84536%
- Food & beverage$1,48664%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Zimmer Biomet | 15 | $1,021 |
| Arthrex | 8 | $546 |
| Pylant Medical | 4 | $272 |
| Stryker | 3 | $125 |
| Pacira Therapeutics, Inc. | 5 | $94 |
| Pacira Pharmaceuticals Incorporated | 3 | $66 |
| Amgen | 3 | $53 |
| Omnilife Science, Inc | 1 | $35 |
| Heron Therapeutics, Inc. | 1 | $29 |
| Innovation Technologies Inc | 1 | $25 |
| Johnson & Johnson | 1 | $23 |
| Radius Health, Inc. | 1 | $15 |
| Treace Medical Concepts, Inc. | 1 | $13 |
| Orthofix Medical, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Avenir$404
- Persona Revision$342
- Revision$127
How this compares
$2,331 in reported general payments places this provider in the 35th percentile of 263 orthopaedic surgery providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 75 | $857 |
| Meloxicam | 178 | $793 |
| Enoxaparin Sodium | 13 | $771 |
| Methylprednisolone | 27 | $260 |
| Celecoxib | 11 | $84 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Altus
- Yogesh MittalTulsa$6.7M
- Andrew ParkinsonOklahoma City$3.1M
- Brian ChalkinTulsa$1.9M
- Carlan YatesOklahoma City$772K
- Bradley ReddickOklahoma City$573K
- Vytautas RingusNorman$332K
- Jason EmersonOklahoma City$189K
- Paul MaitinoOklahoma City$176K
- Sarat KunapuliTulsa$170K
- Ronald DumiganOklahoma City$169K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.